Congratulations to second year Molecular Pharmaceutics graduate student, Fatemeh Zarei, for presenting her research, “Evaluating Therapeutic Efficacy of GM-1111 via Distinct Administration Routes in Chronic Rhinosinusitis,” at the recent 2025 American Rhinologic Society Meeting at COSM in New Orleans, LA (May 17, 2025)! Her work seeks to develop a new non-steroidal anti-inflammatory agent in treating upper and lower airway inflammation in patients with CRS and asthma.
Thanks for representing the UROC Innovations Lab, Fatemeh. We are proud of you!
